News

EpiCept, a specialty pharmaceutical company, has announced that the FDA indicated that the company has the necessary pivotal data to file a new drug application for Ceplene in

In his role as vice president of preclinical development, Mr Tabrizi will guide the company’s therapeutic antibody discovery programs into clinical development. He will also lead compound assessment,

Under an exclusive marketing agreement, Neurobiological Technologies (NTI) currently receives quarterly royalty payments on certain sales of Memantine by Merz and its marketing partners.

The placebo-controlled, randomized trial is a parallel-group dose-response study of the ability of ITX5061 to reduce viral load in treatment-naive and previously treated patients with hepatitis C virus

The collaboration will include studies of cancer-related microRNAs that were discovered at both Mirna and University of California, San Francisco (UCSF) as well as small RNAs that will

Tepnel’s board of directors intends to recommend that its shareholders approve the transaction, which is expected to close in the second quarter of 2009. Already, directors and institutional

CyDex has an international patent cooperation treaty application pending for this combination nasal spray product. A randomized, double-blind, placebo-controlled, three-way cross-over study was conducted in 108 seasonal allergic

Mr Rainey began his career as staff account manager at Ernst & Young in Philadelphia. From 1997-2008 at Avax, Mr Rainey held several leadership positions including CEO, president,

The suit was brought in the US District Court of Delaware. Two patents at issue in this suit, related to Masimo’s measure-through-motion technology, were successfully enforced in a